 | | | | - Compared with industrial mean, the Return On Risk is rather low | | - All related stocks also increase. Medical Supplies industry +1.75% | | - Individuals and Foreigners buy, Institutions sell | | - Turnover Rate and Price Range both proper | | - The main shareholding group is Individuals |
|
|
On Oct. 27 01:40 P.M., CKD Bio increased 1.71% to 23,850 won (US$20.97). It had declined 11.99% through the past month. Standard deviation, the volatility index for stock price, was 1.9% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, CKD Bio was not only satisfactory in investment return among its peer group, but its volatility was also the lowest. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.3%. As the volatility was low, the return-on-risk was a proper rate in spite of stock price decline. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, -3.3, and thus it is hard to say that the industrial comparison performance was positive.
Comparing industry to the market, the KOSPI industry including CKD Bio records higher volatility but lower earning rate than Medical Supplies. Even though the earning rate of the industry is negative, the industry was more satisfactory than the market.
| Close Competitors | Earning rate (%) | STD (1Mo) | Return on
Risk (1Mo) | | 1 Mo | 3 Mo | 6 Mo | | MYUNGMOON PHARM(017180) | -10.7% | -25.1% | -1.3% | 3.2% | -3.3 | | HYUNDAI PHARM(004310) | -12.9% | -15.7% | 5.4% | 2.9% | -4.4 | | SAMSUNG PHARM(001360) | -20.9% | -34.4% | -26.0% | 2.6% | -8.0 | | DONGSUNG PHARM(002210) | -15.2% | -23.3% | -23.7% | 2.2% | -6.9 | | CKD Bio(063160) | -12.0% | -18.6% | -12.3% | 1.9% | -6.3 | | | | Medical Supplies | -21.1% | -17.9% | -19.9% | 1.7% | -12.4 | | KOSPI | -2.0% | -1.1% | 0.4% | 0.6% | -3.3 |
|
CKD Bio(063160): 2Q(Apr ~ June) of 2016 Earnings (reported at July 29. 2016)
| | Revenue | Operating Income | Net Income | | 2Q of 2016 | 276.7 T | 33.5 T | 30.8 T | | Previous Quarter | 4.0% decline | 26.8% decline | 5.4% decline | | YoY | 2.4% decline | 353.0% increase | 261.8% increase |
|
Financial structure Overview
| Compared with 4 close competitors with similar market capitalization within its industry, CKD Bio's P/B ratio, a financial ratio of a company's book value, and its P/E ratio, a price-paid ratio of annual net income, are both at the lowest level. |
P/E ratio and P/B ratio
| Close Compatitors | ROE | PER | PBR | Basic Date | | CKD Bio(063160) | 8.6 | 10.8 | 0.9 | June 2016 | | SAMSUNG PHARM(001360) | -20.7 | - | 3.0 | June 2016 | | DONGSUNG PHARM(002210) | -3.4 | - | 1.7 | June 2016 | | HYUNDAI PHARM(004310) | 1.6 | 81.5 | 1.3 | May 2016 | | MYUNGMOON PHARM(017180) | -14.7 | - | 1.6 | June 2016 |
Individuals and Foreigners buy, Institutions sell
While institutions have been selling CKD Bio during the past 3 trading days, foreigners have been buying during the past 4 trading days. As a shareholding sum by investor group for the past 4 weeks, foreigners have bought 30,243 shares with a maintenance of shareholding and Individuals have bought 14,357 shares lessening its position. However, during the same period, Institutions have sold 44,600 shares with a selling trend.
Turnover Rate and Price Range both proper
Regarding the statistics for the past month on trade volume as the total outstanding shares, the daily turnover rate of CKD Bio was 0.44%. And the daily volatility, the average range of rise and fall, during the same period is 3.4%.
The main shareholding group is Individuals
As per the inquiry for shareholding by investor group, the major investor group is individuals with 82.39% from total outstanding shares. Foreigners and institutions each hold 12.64% and 4.96%. And as recent 5-day shareholding change by investor group, individuals is the major investor group with 80.36%. Foreigners hold 19.5% and institutions hold 0.12%.
| Cumulated shareholdings per investor group (1Mo) | | Total shareholdings per investor group |  | |  |
| * Other Investor groups, included as "other corporations", are considered as "Individuals". |
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp. |
![[KH Explains] No more 'Michael' at Kakao Games](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=645&simg=/content/image/2024/04/28/20240428050183_0.jpg&u=20240428180321)
